Mmh. Marijianowski et al., DILATED CARDIOMYOPATHY IS ASSOCIATED WITH AN INCREASE IN THE TYPE-I TYPE-III COLLAGEN RATIO - A QUANTITATIVE ASSESSMENT/, Journal of the American College of Cardiology, 25(6), 1995, pp. 1263-1272
Objectives. The aim of this study was to quantify total collagen and t
he type I/type III collagen ratio and their localization in hearts wit
h dilated cardiomyopathy. Background. Patients with dilated cardiomyop
athy have an increase in intramyocardial fibrillar collagen. Types I a
nd III are the main constituents and have different physical propertie
s that may affect cardiac compliance. Methods. Nineteen hearts with di
lated cardiomyopathy were studied (17 cardiac explants, 2 hearts obtai
ned at autopsy) and compared with reference hearts. Total collagen was
determined by hydroxyproline analysis. Collagen types I and III were
analyzed using the cyanogen bromide method and immunohistochemical ana
lysis followed by microdensitophotometric quantification. Localization
of collagen types I and III was established at the light and electron
microscopic levels. Immunoelectron microscopy provided information re
garding their localization. Results. Total collagen and the collagen t
ype I/type III ratio were increased in hearts with dilated cardiomyopa
thy (p < 0.05). Electron microscopy shoved a diffuse increase in colla
gen fibrils in the endomysium; the perimysium showed an inhomogeneous
increase. Collagen fibrils were thicker, and fibrous long-spacing coll
agen occurred in the endomysium. Immunoelectron microscopic findings c
onfirmed an increase in type I collagen. Conclusions. Hearts with dila
ted cardiomyopathy have a statistically significant increase in the co
llagen type I/type III ratio. The changes occur in the endomysium and
perimysium, although with differences in distribution. These changes i
n intramyocardial collagen may be clinically relevant because they may
affect cardiac rigidity and, therefore, eventually may render the hea
rt less compliant. Further studies are needed to evaluate at what poin
t in the course of the disease these changes appear.